Q2 2024 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2024-08-14 · accession 0001214659-24-014668
$383.4M
Reported value
19
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91529Y106 | UNM | UNUM GROUP | $47.6M | 12.4% | 930,545 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $43.6M | 11.4% | 637,315 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $43.6M | 11.4% | 131,926 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $29.5M | 7.68% | 99,094 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $26.6M | 6.93% | 106,360 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $24.1M | 6.29% | 721,278 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $20.0M | 5.22% | 94,734 | Common | SOLE |
| 03209R103 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $19.8M | 5.17% | 495,089 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $17.9M | 4.67% | 523,679 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $16.2M | 4.23% | 699,966 | Common | SOLE |
| 08579W103 | BERYEUR | BERRY GLOBAL GROUP INC | $15.3M | 3.99% | 259,710 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $14.8M | 3.86% | 422,049 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $10.3M | 2.68% | 775,368 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $10.0M | 2.60% | 48,288 | Common | SOLE |
| 15687V109 | CERT | CERTARA INC | $10.0M | 2.60% | 718,983 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $9.8M | 2.55% | 250,460 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $9.3M | 2.42% | 174,766 | Common | SOLE |
| 421906108 | HCSG | HEALTHCARE SVCS GROUP INC | $9.2M | 2.41% | 873,018 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $5.9M | 1.53% | 216,047 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.